MHRA

How to get a parallel import licence for your medicine in the UK, including pharmacovigilance requirements and submitting your application.

How to make a payment by credit or debit card or a bank transfer for all applications except Device Registration and Certificates of Free Sale applications.

More than 40 people hospitalised following suspected use of unlicensed botulinum toxin products.

Summary of the latest safety advice for medicines and medical device users

As with any medicine, the MHRA will keep the safety of gepotidacin under close review.

As with any medicine, the MHRA will keep the safety of zuranolone under close review.

The pilot will help sponsors prepare for a new substantial modifications process under upcoming regulations, with responses delivered within 14 days.

List of Field Safety Notices from 18 to 22 August 2025.

Information for patients, public and healthcare professionals

New Cosmetic Breast Augmentation Risk Awareness Tool for patients to use when considering cosmetic breast implant surgery.

Ipca Laboratories UK Ltd has informed the MHRA that the Patient Information Leaflet (PIL) in the products listed in this notification do not contain all the required safety information.

How to apply for a clinical trial including eligibility, phases, model IMPDs, costs and how to make changes to your application.